TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation

被引:8
作者
Wu, Lian-pan [1 ,2 ,3 ]
Gong, Zheng-fan [1 ,2 ,3 ]
Wang, He [1 ,2 ,3 ]
Zhou, Zhong-shu [1 ,2 ,3 ]
Zhang, Ming-ming [1 ,2 ,3 ]
Liu, Chao [1 ,2 ,3 ]
Ren, Hong-mei [1 ,2 ,3 ]
Yang, Jian [1 ,2 ,3 ]
Han, Yu [1 ,2 ,3 ]
Zeng, Chun-yu [1 ,2 ,3 ]
机构
[1] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing 400042, Peoples R China
[2] Chongqing Inst Cardiol, Chongqing 400042, Peoples R China
[3] Chongqing Key Lab Hypertens Res, Chongqing 400042, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
neointima formation; vascular smooth muscle cells; proliferation; TSPO; AMPK; PDGF-BB; PK11195; Ro5-4864; compound C; balloon-injured carotid arteries; TRANSLOCATOR PROTEIN TSPO; 18 KDA TSPO; PHENOTYPIC SWITCH; KINASE; ENERGY; ATHEROSCLEROSIS; APOPTOSIS; SENSOR; PDGF;
D O I
10.1038/s41401-019-0293-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Abnormal growth of the intimal layer of blood vessels (neointima formation) contributes to the progression of atherosclerosis and in-stent restenosis. Recent evidence shows that the 18-kDa translocator protein (TSPO), a mitochondrial membrane protein, is involved in diverse cardiovascular diseases. In this study we investigated the role of endogenous TSPO in neointima formation after angioplasty in vitro and in vivo. We established a vascular injury model in vitro by using platelet-derived growth factor-BB (PDGF-BB) to stimulate rat thoracic aortic smooth muscle cells (A10 cells). We found that treatment with PDGF-BB (1-20ng/mL) dose-dependently increased TSPO expression in A10 cells, which was blocked in the presence of PKC inhibitor or MAPK inhibitor. Overexpression of TSPO significantly promoted the proliferation and migration in A10 cells, whereas downregulation of TSPO expression by siRNA or treatment with TSPO ligands PK11195 or Ro5-4864 (10(4)nM) produced the opposite effects. Furthermore, we found that PK11195 (10-10(4)nM) dose-dependently activated AMPK in A10 cells. PK11195-induced inhibition on the proliferation and migration of PDGF-BB-treated A10 cells were abolished by compound C (an AMPK-specific inhibitor, 10(3)nM). In rats with balloon-injured carotid arteries, TSPO expression was markedly upregulated in the carotid arteries. Administration of PK11195 (3mg/kg every 3 days, ip), starting from the initial balloon injury and lasting for 2 weeks, greatly attenuated carotid neointima formation by suppressing balloon injury-induced phenotype switching of VSMCs (increased alpha -SMA expression). These results suggest that TSPO is a vascular injury-response molecule that promotes VSMC proliferation and migration and is responsible for the neointima formation after vascular injury, which provides a novel therapeutic target for various cardiovascular diseases including atherosclerosis and restenosis.
引用
收藏
页码:34 / 46
页数:13
相关论文
共 36 条
[21]   Functional gains in energy and cell metabolism after TSPO gene insertion [J].
Liu, Guo-Jun ;
Middleton, Ryan J. ;
Kam, Winnie Wai-Ying ;
Chin, David Y. ;
Hatty, Claire R. ;
Chan, Ronald H. Y. ;
Banati, Richard B. .
CELL CYCLE, 2017, 16 (05) :436-447
[22]   Apoptosis and cell proliferation after porcine coronary angioplasty [J].
Malik, N ;
Francis, SE ;
Holt, CM ;
Gunn, J ;
Thomas, GL ;
Shepherd, L ;
Chamberlain, J ;
Newman, CMH ;
Cumberland, DC ;
Crossman, DC .
CIRCULATION, 1998, 98 (16) :1657-1665
[23]   The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines [J].
Mendonca-Torres, Maria C. ;
Roberts, Stephen S. .
CANCER BIOLOGY & THERAPY, 2013, 14 (04) :319-326
[24]   Molecular regulation of vascular smooth muscle cell differentiation in development and disease [J].
Owens, GK ;
Kumar, MS ;
Wamhoff, BR .
PHYSIOLOGICAL REVIEWS, 2004, 84 (03) :767-801
[25]   A newly synthesized Ligustrazine stilbene derivative inhibits PDGF-BB induced vascular smooth muscle cell phenotypic switch and proliferation via delaying cell cycle progression [J].
Peng, Chunlian ;
Zhang, Siming ;
Liu, Haixin ;
Jiao, Yanxiao ;
Su, Guifa ;
Zhu, Yan .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 814 :106-113
[26]   AMPK: energy sensor and survival mechanism in the ischemic heart [J].
Qi, Dake ;
Young, Lawrence H. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2015, 26 (08) :422-429
[27]   PDGF and cardiovascular disease [J].
Raines, EW .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :237-254
[28]  
Repalli Jayanthi, 2014, Curr Aging Sci, V7, P168
[29]   Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders [J].
Rupprecht, Rainer ;
Papadopoulos, Vassilios ;
Rammes, Gerhard ;
Baghai, Thomas C. ;
Fan, Jinjiang ;
Akula, Nagaraju ;
Groyer, Ghislaine ;
Adams, David ;
Schumacher, Michael .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (12) :971-988
[30]   Cancer cell cycles [J].
Sherr, CJ .
SCIENCE, 1996, 274 (5293) :1672-1677